Cart
sales@molnova.com
AZ 11645373
CAS No. 227088-94-0
AZ 11645373( 3-[1-[[(3'-NITRO[1,1'-BIPHENYL]-4-YL)OXY]METHYL]-3-(4-PYRIDINYL)PROPYL]-2,4-THIAZOLIDINEDIONE )
Catalog No. M27445 CAS No. 227088-94-0
AZ 11645373 is a highly selective and potent human P2X7 receptor antagonist that has no effect on mouse/rat P2X7 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 240 | Get Quote |
|
| 10MG | 347 | Get Quote |
|
| 25MG | 582 | Get Quote |
|
| 50MG | 830 | Get Quote |
|
| 100MG | 1125 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAZ 11645373
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZ 11645373 is a highly selective and potent human P2X7 receptor antagonist that has no effect on mouse/rat P2X7 receptor.
-
DescriptionAZ 11645373 is a highly selective and potent human P2X7 receptor antagonist that has no effect on mouse/rat P2X7 receptor.
-
In Vitro——
-
In Vivo——
-
Synonyms3-[1-[[(3'-NITRO[1,1'-BIPHENYL]-4-YL)OXY]METHYL]-3-(4-PYRIDINYL)PROPYL]-2,4-THIAZOLIDINEDIONE
-
PathwayMembrane Transporter/Ion Channel
-
TargetP2X Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number227088-94-0
-
Formula Weight463.51
-
Molecular FormulaC24H21N3O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[O-][N+](=O)c1cccc(c1)-c1ccc(OCC(CCc2ccncc2)N2C(=O)CSC2=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qiao-yu Yuan,et al. Chemical Constituents from Cremastra appendiculata. Zhong Yao Cai. 2015 Feb;38(2):298-301.
molnova catalog
related products
-
JNJ-54175446
JNJ-54175446 (JNJ-5446) is a CNS-permeable and selective P2X7 receptor antagonist that attenuates the release of IL-1β/IL-18 from microglia, and may be used in the study of depression.
-
AZD-9056 hydrochlori...
A potent, selective, orally bioavailable P2X7 receptor antagonist; inhibits release of pro-inflammatory mediators from isolated human peripheral monocytes (IL-1β and IL-18) and human alveolar macrophages (IL-1β) with IC50 values of 10-13 nM.
-
JNJ-55308942
JNJ-55308942 is a novel highly potent P2X7 antagonist with Ki of 1.0 and 6.5 nM for rat and human hP2X7, demonstrates significant activity against a panel of related P2X receptors (P2X1, P2X2, P2X3, P2X2/3, and P2X4; also shows insignificant inhibition of nine CYP isoforms (IC50>15 uM).
